mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.05 |
mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.05 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.09 |
0.05 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
0.091 |
0.06 |
mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.06 |